MINNETONKA, MN -- May 10, 1999 -- LecTec Corporation (Nasdaq National Market: LECT) today announced the signing of a letter of intent with Johnson & Johnson Consumer Products Company, a wholly-owned subsidiary of Johnson & Johnson (NYSE: JNJ), to develop a skin care product utilizing LecTec Corporation's proprietary skin interface technologies.

Johnson & Johnson Consumer Products Company will conduct limited efficacy and consumer studies to confirm the consumer acceptance of the prototype product. Upon successful completion of the studies, the satisfaction of certain milestones defined by the letter of intent, and a final decision to commercialize the product, LecTec Corporation will begin to manufacture product for Johnson & Johnson Consumer Products Company.

"We are pleased to be working with Johnson & Johnson Consumer Products Company to develop a new and innovative, high-quality skin care product," commented Rodney A. Young, chairman, CEO and president of LecTec Corporation. "This project further demonstrates our commitment to expand LecTec Corporation's skin interface technology platform," stated Young.

LecTec Corporation is a health care and consumer products company that develops, manufactures and markets products based on its advanced skin interface technologies. Primary products include diagnostic electrodes and conductive hydrogels for electrocardiography and related applications, a full line of medical tapes, and over-the-counter therapeutic patches.

                  CONTACT: LecTec Corporation, Minnetonka
Rodney A. Young, CEO
or
Jane M. Nichols, VP Marketing & New
Business Development
612/933-2291
or
800-777-2291